WHSI yields 2000000.00% · JNJ yields 2.13%● Live data
📍 WHSI pulled ahead of the other in Year 1
Combined, WHSI + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of WHSI + JNJ for your $10,000?
Wearable Health Solutions, Inc. provides personal response monitoring services and related products to subscribers with medical or age-related conditions in the United States. The company manufactures medical alarm devices that are used to summon help in the event of an emergency. It offers MediPendant, a medical alarm product with speaker in the pendant that enables the user to simply speak and listen directly through the pendant in the event of an emergency; and iHelp, a mobile medical alarm device that utilizes T-Mobile's 2G network to remotely locate a loved one and voice prompts, as well as a dealer portal that enables dealers to manage their own iHelp customer base. The company is also designing and developing iHelp+3G, a wearable biosensor device for health and wellness that operates on 3G network. It offers its products primarily for the elderly and physically disabled, as well as for persons living alone. The company markets its products through its Websites, medipendant.com, and ihelpalarm.com; and wholesalers, as well as distributes its products in Denmark, Ireland, Bermuda, and the People's Republic of China. The company was formerly known as Medical Alarm Concepts Holdings, Inc. and changed its name to Wearable Health Solutions, Inc. in June 2016. Wearable Health Solutions, Inc. was founded in 2008 and is based in Las Vegas, Nevada.
Full WHSI Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.